UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055662
Receipt number R000059518
Scientific Title Online musical intervention to promote emotional stability and self-esteem improvement for abused children during the COVID-19 pandemic.
Date of disclosure of the study information 2024/09/29
Last modified on 2024/09/28 18:01:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Online musical intervention to promote emotional stability and self-esteem improvement during the COVID-19 pandemic.

Acronym

Online musical intervention to promote emotional stability and self-esteem improvement during the COVID-19 pandemic.

Scientific Title

Online musical intervention to promote emotional stability and self-esteem improvement for abused children during the COVID-19 pandemic.

Scientific Title:Acronym

Online musical intervention to promote emotional stability and self-esteem improvement for abused children during the COVID-19 pandemic.

Region

Japan


Condition

Condition

abused children in foster care

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we aim to investigate the effects of musical intervention on the mental and behavioral issues of abused children. Compared to pharmacological treatment, musical intervention, which has almost no adverse effects, is expected to show potential improvements in mental symptoms and behavioral problems. This could significantly contribute to the development of therapeutic approaches for children seeking psychiatric care. Considering the current impact of the COVID-19 pandemic, we plan to conduct the intervention online. Looking ahead, we anticipate that this approach could also have a significant impact on children in underserved areas, such as remote and island regions, where resources for healthcare and education are limited.

For children, the idea of hospital visits and pharmacological treatment can be daunting. Therapeutic intervention through a familiar and enjoyable medium like music is highly valuable. We believe in exploring the power of music not only to "resolve emotional distress," but also to "enrich lives" and "boost self-esteem."

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The following items will be assessed before and after the intervention.
QIDS-J Quick Inventory of Depressive Symptomatology
AFQ-Y Avoidance and Fusion Questionnaire for Youth
SCAS Spence Children's Anxiety Scale
SDQ Strengths and Difficulties Questionnaire
ADHD-RS-4 ADHD Rating Scale
ABC-J Aberrant behavior checklist
SDQ-P Strengths and Difficulties Questionnaire
SCAS-P Spence Childrens Anxiety Scale
The above items will also be assessed at 3 and 6 months after the end of the intervention to verify the long-term progress.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

The online environment will be used to teach the subject how to play guitar, drums, or any other instrument of his/her choice. There will be a total of 10 sessions every other week.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

18 years-old >=

Gender

Male and Female

Key inclusion criteria

The program will be open to those who meet all of the following criteria
1. Age: At least 6 years old and no older than 18 years old at the time of obtaining consent.
2. Gender: Any gender
3. Abused children in foster care facilities
4. Persons who have been fully informed about their participation in this study, and who have given their assent and written consent based on sufficient understanding by themselves or by their surrogate.

Key exclusion criteria

Persons who fall under any one of the following shall be excluded as eligible
1. Those whose age is less than 6 years old or more than 19 years old
2. Persons with hearing impairment
3. Persons with visual impairment
4. Other patients deemed inappropriate as research subjects by the principal investigator.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Shintaro
Middle name
Last name Fukumoto

Organization

University of Fukui

Division name

Department of Neuropsychiatry, Faculty of Medical Sciences, University of Fukui

Zip code

9101193

Address

23-3, Matsuoka-shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan

TEL

0776613111

Email

sinchan@u-fukui.ac.jp


Public contact

Name of contact person

1st name Shintaro
Middle name
Last name Fukumoto

Organization

University of Fukui

Division name

Department of Neuropsychiatry, Faculty of Medical Sciences, University of Fukui

Zip code

9101193

Address

23-3, Matsuoka-shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan

TEL

0776613111

Homepage URL


Email

sinchan@u-fukui.ac.jp


Sponsor or person

Institute

Department of Neuropsychiatry, Faculty of Medical Sciences, University of Fukui
Shintaro Fukumoto

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Neuropsychiatry, Faculty of Medical Sciences, University of Fukui

Address

23-3, Matsuoka-shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan

Tel

0776613111

Email

sinchan@u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

6

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 08 Month 01 Day

Date of IRB

2022 Year 09 Month 26 Day

Anticipated trial start date

2022 Year 10 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 09 Month 28 Day

Last modified on

2024 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059518